Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma

Hepatology Research

Volumn 29, Issue 2, 2004, Pages 113-121

  Hwang, Yeo Hyeon ^a   Choi, Jong Young ^b   Kim, Soyoun ^c   Chung, Eun Sun ^d   Kim, Taeuk ^c   Koh, Sang Seok ^c   Lee, Bogman ^c   Bae, Si Hyun ^b   Kim, Jin ^e   Park, Young Min ^f  

^a The Catholic University of Korea   (South Korea)

^b Department of Internal Medicine ^*  (South Korea)

^c LG Chemical Ltd   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

^f Bundang Jesaeng Hospital   (South Korea)

Author keywords

Hepatocarcinogenesis; Hepatocellular carcinoma; Liver cirrhosis; MAPK pathway; Raf 1; Ribosomal protein S6

Indexed keywords

COMPLEMENTARY DNA; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 2442637885     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.02.009     Document Type: Article

References (55)

1. Durr R. Caselmann W.H. Carcinogenesis of primary liver malignancies Langenbecks Arch. Surg. 385 2000 154-161
2. Dominguez-Malagon H. Gaytan-Graham S. Hepatocellular carcinoma: an update Ultrastruct. Pathol. 25 2001 497-516
3. Okuda K. Hepatocellular carcinoma J. Hepatol. 32 Suppl 1 2000 225-237
4. Fausto N. Liver regeneration J. Hepatol. 32 2000 19-31
5. Masson S. Scotte M. Garnier S. et al. Differential expression of apoptosis-associated genes post-hepatectomy in cirrhotic vs. normal rats Apoptosis 5 2000 173-179
6. Park Y.N. Chae K.J. Kim Y.B. Park C. Theise N. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis Cancer 92 2001 2733-2738
7. Hatanaka Y. Nakae D. Mutai M. et al. Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats Jpn. J. Cancer Res. 92 2001 1270-1277
8. Kountouras J. Boura P. Lygidakis N.J. Liver regeneration after hepatectomy Hepatogastroenterology 48 2001 556-562
9. Hanahan D. Weinberg R.A. The hallmarks of cancer Cell 100 2000 57-70
10. Medema R.H. Bos J.L. The role of p21ras in receptor tyrosine kinase signaling Crit. Rev. Oncog. 4 1993 615-661
11. Saavedra H.I. Fukasawa K. Conn C.W. Stambrook P.J. MAPK mediates RAS-induced chromosome instability J. Biol. Chem. 274 1999 38083-38090
12. Saavedra H.I. Knauf J.A. Shirokawa J.M. et al. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway Oncogene 19 2000 3948-3954
13. Davies H. Bignell G.R. Cox C. et al. Mutations of the BRAF gene in human cancer Nature 17 2002 949-954
14. Brose M.S. Volpe P. Feldman M. et al. BRAF and RAS mutations in human lung cancer and melanoma Cancer Res. 62 2002 6997-7000
15. Chen N. She Q.B. Bode A.M. Dong Z. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells Cancer Res. 62 2002 1300-1304
16. Kim Y. Gharaibeh S.M. Stedman N.L. Brown T.P. Comparison and verification of quantitative competitive reverse transcription polymerase chain reaction (QC-RT-PCR) and real time RT-PCR for avian leukosis virus subgroup J. Virol. Methods 102 2002 1-8
17. Quakenbush J. Computational analysis of microarray data Nat. Rev. Genet. 26 2001 418-427
18. Tavazoie S. Hughes J.D. Campbell M.J. Chos R.J. Church G.M. Systematic determination of genetic network architecture Nat. Genet. 22 1999 281-285
19. Golub T.R. Slonim D.K. Tamayo P. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 86 1999 531-537
20. Rapp U.R. Goldsborough M.D. Mark G.E. et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus Proc. Natl. Acad. Sci. U.S.A. 80 1983 4218-4222
21. Bonner T.I. Oppermann H. Seeburg P. et al. The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene Nucl. Acids Res. 14 1986 1009-1015
22. Rapp U.R. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction Oncogene 6 1991 495-500
23. Yao B. Zhang Y. Delikat S. Mathias S. Basu S. Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase Nature 378 1995 307-310
24. Kasid U. Suy S. Dent P. Ray S. Whiteside T.L. Sturgill T.W. Activation of Raf by ionizing radiation Nature 382 1996 813-816
25. Cleveland J.L. Troppmair J. Packham G. et al. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells Oncogene 9 1994 2217-2226
26. Wang H.G. Miyashita T. Takayama S. et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase Oncogene 9 1994 2751-2756
27. Blagosklonny M.V. Schulte T. Nguyen P. Trepel J. Neckers L.M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway Cancer Res. 56 1996 1851-1854
28. Wojnowski L. Zimmer A.M. Beck T.W. et al. Endothelial apoptosis in Braf-deficient mice Nat. Genet. 16 1997 293-297
29. Slater E.P. Stubig T. Lau Q.C. Achenbach T.V. Rapp U.R. Muller R. c-Raf controlled pathways in the protection of tumor cells from apoptosis Int. J. Cancer 104 2003 425-432
30. Kolch W. Heidecker G. Lloyd P. Rapp U.R. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells Nature 349 1991 426-428
31. Kerkhoff E. Rapp U.R. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1 Mol. Cell. Biol. 17 1997 2576-2586
32. Callans L.S. Naama H. Khandelwal M. Plotkin R. Jardines L. Raf-1 protein expression in human breast cancer cells Ann. Surg. Oncol. 2 1995 38-42
33. Ravi R.K. Weber E. McMahon M. et al. Activated Raf-1 causes growth arrest in human small cell lung cancer cells J. Clin. Invest. 101 1998 153-159
34. Schmidt C.A. Oettle H. Ludwig W.D. et al. Overexpression of the Raf-1 proto-oncogene in human myeloid leukemia Leuk. Res. 18 1994 409-413
35. Storm S.M. Brennscheidt U. Sithanandam G. Rapp U.R. raf oncogenes in carcinogenesis Crit. Rev. Oncog. 2 1990 1-8
36. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK Proc. Natl. Acad. Sci. U.S.A. 90 1993 5889-5892
37. Cantley L.C. Auger K.R. Carpenter C. et al. Oncogenes and signal transduction Cell 64 1991 281-302
38. Pelech S.L. Sanghera J.S. MAP kinases: charting the regulatory pathways Science 257 1992 1355-1356
39. Williams N.G. Roberts T.M. Signal transduction pathways involving the Raf proto-oncogene Cancer Metastasis Rev. 13 1994 105-116
40. Morrison D.K. Mechanisms regulating Raf-1 activity in signal transduction pathways Mol. Reprod. Dev. 42 1995 507-514
41. Krautwald S. Buscher D. Dent P. Ruthenberg K. Baccarini M. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase Oncogene 10 1995 1187-1192
42. Takada S. Koike K. Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells Oncogene 4 1989 189-193
43. Watatani M. Perantoni A.O. Reed C.D. Enomoto T. Wenk M.L. Rice J.M. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats Cancer Res. 49 1989 1103-1109
44. Radosevich J.A. Gould K.A. Koukoulis G.K. et al. Immunolocalization of ras oncogene p21 in human liver diseases Ultrastruct. Pathol. 17 1993 1-8
45. Himeno Y. Fukuda Y. Hatanaka M. Imura H. Expression of oncogenes in human liver disease Liver 8 1988 208-212
46. Zhang X.K. Huang D.P. Chiu D.K. Chiu J.F. The expression of oncogenes in human developing liver and hepatomas Biochem. Biophys. Res. Commun. 142 1987 932-938
47. Masaki T. Okada M. Shiratori Y. et al. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats Hepatology 27 1998 1257-1264
48. Ito Y. Kawakatsu H. Takeda T. et al. Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype J. Hepatol. 35 2001 68-73
49. McKillop I.H. Schmidt C.M. Cahill P.A. Sitzmann J.V. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma Hepatology 26 1997 1484-1491
50. Ito Y. Sasaki Y. Horimoto M. et al. Activation of mitogen-activated protein kinases/extracellular signal- regulated kinases in human hepatocellular carcinoma Hepatology 27 1998 951-958
51. Nemenoff R.A. Price D.J. Mendelsohn M.J. Carter E.A. Avruch J. An S6 kinase activated during liver regeneration is related to the insulin-stimulated S6 kinase in H4 hepatoma cells J. Biol. Chem. 263 1988 19455-19460
52. Lawen A. Burger M. Martini O.H. Mitogen-responsive S6 kinase Eur. J. Biochem. 183 1989 245-253
53. Comolli R. Alberti P. Giribaldi G. Activation of a ribosomal S6 protein kinase in rapidly emerging diethylnitrosamine-induced gamma-glutamyltranspeptidase-positive hyperplastic liver lesions of the rat Tumori 75 1989 527-532
54. Daya-Makin M. Sanghera J.S. Mogentale T.L. et al. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung Cancer Res. 54 1994 2262-2268
55. Barnard G.F. Staniunas R.J. Mori M. et al. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma Cancer Res 53 1993 4048-4052